BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Drug Discovery

Suzhou Ribo Life Science And Insilico Medicine Forge Strategic Alliance To Accelerate AI Powered siRNA Drug Development

Suzhou Ribo Life Science Co., Ltd. ("Ribo", 06938.HK) announced that the Company has entered into a strategic collaboration agreement with Insilico Me...

May 14, 2026 | News

Isomorphic Labs Raises $2.1 Billion To Scale AI Driven Drug Discovery Platform

Isomorphic Labs will use the funding to power its world-leading AI drug design engine, scale its business globally and progress its drug candidate pipeline...

May 14, 2026 | News

GenScript Biotech Launches TurboCHO Protein Expression Kit To Accelerate Antibody Discovery Workflows

New kit offers researchers and development teams a meaningful advance in expression speed and output GenScript Biotech Corporation announced the laun...

May 14, 2026 | News

Benchling Launches Antibody R&D Platform To Accelerate Biologics Discovery And Development

Benchling announced Benchling Biologics, an end-to-end platform for antibody R&D, today at the PEGS Boston Summit. Scientists can configure a...

May 13, 2026 | News

Cellenkos Advances CK0802 Into Phase 1b 2a Trial Following FDA Clearance For Steroid Refractory GVHD

Multicenter, open-label study will evaluate the safety and preliminary efficacy of CK0802, a first-in-class, off-the-shelf Treg therapy, in patients with s...

May 06, 2026 | News

Quantum Breakthrough Enables Largest Ever Protein Simulations Advancing Drug Discovery Potential

Scientists at Cleveland Clinic, RIKEN, and IBM (NYSE: IBM) have used IBM quantum computers and two of the world's most powerful supercomputers to simu...

May 06, 2026 | News

UltraGreen.ai Secures Singapore Approval For Verdye Strengthening Southeast Asia Surgical Innovation Strategy

Approval in a strategic healthcare hub strengthens regional growth strategy and supports clinical adoption of fluorescence-guided surgery Ultr...

May 06, 2026 | News

EnGeneIC Doses First Patient In Trial Targeting Recurrent Glioblastoma

EnGeneIC announced that the first patient has been dosed in its clinical trial evaluating EnGeneIC’s investigational EGFR-targeted EDV™ (EnGene...

May 05, 2026 | News

Restore Vision Reports Encouraging Phase I II Data For RV 001 Gene Therapy In Retinitis Pigmentosa

Phase I/II clinical trial interim results, out to 168 days, from the two RV-001 dosing cohorts with advanced Retinitis Pigmentosa are presented at key Ma...

May 04, 2026 | News

Genexine Advances First In Class SOX2 Targeting BioPROTAC GX BP1 With Strong Preclinical Anti Tumour Data

Genexine, Inc. (KOSDAQ: 095700), a clinical-stage biotechnology company, announced new preclinical data for its SOX2-targeting bioPROTAC candidate, G...

May 04, 2026 | News

Insilico Medicine Secures IND Clearance For Rentosertib Inhalation Solution To Advance Targeted IPF Therapy

Following positive Phase IIa results for oral Rentosertib in GENESIS-IPF with good tolerability, a favorable PK profile, and dose-dependent efficacy impr...

April 30, 2026 | News

Cordis Launches SELUTION SLR Drug Eluting Balloon In Japan For Peripheral Artery Disease

Cordis, a global leader in interventional cardiovascular technologies, today announces the launch and availability of the SELUTION SLR™ PTA Drug...

April 29, 2026 | News

Becton Dickinson and Company And Suttons Creek Partner To Streamline Combination Product Development

The collaboration brings together consulting, device agnostic testing, and drug delivery expertise to help pharmaceutical and biotech companies reduce risk...

April 29, 2026 | News

HanchorBio, Inc. Partners With Bloomberg To Strengthen Data Driven Biopharma Strategy

Expanding HanchorBio's data-enabled approach from molecule design to portfolio and market insight -- HanchorBio, Inc. (TPEx: 7827), a global clinical-stag...

April 27, 2026 | News

Stay Connected